lol
a bit p'd off about today's webinar, and rightfully so.
I'll start signing off again with my 2024 the year of ADO when I feel confident the company is capable of closing a commercial deal, until then I feel it'd be disingenuous of me to sign off with it.
As for the webinar, DR was unapologetic about missing all life science KPI's. Said the targets were too ambitious or words to that effect.
Heck, his job was to commercialize a 'market ready' product. We're meant to be a 'revenue stage' company but we're still stuck reliant on capital raisings.
Ewen has been with us nearly 2 years, David 18 months and we're still being run like an R&D company.
No marketing. The investment world doesn't know about us. We won awards back in 2022 which were meant to lead to funding. I wonder if Ed Husic and others even remember who we are?
We flounder here at sub 3c
Give us something of substance David
